Correlation Between Ventyx Biosciences and Travere Therapeutics
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Travere Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Travere Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Travere Therapeutics, you can compare the effects of market volatilities on Ventyx Biosciences and Travere Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Travere Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Travere Therapeutics.
Diversification Opportunities for Ventyx Biosciences and Travere Therapeutics
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Ventyx and Travere is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Travere Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Travere Therapeutics and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Travere Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Travere Therapeutics has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Travere Therapeutics go up and down completely randomly.
Pair Corralation between Ventyx Biosciences and Travere Therapeutics
Given the investment horizon of 90 days Ventyx Biosciences is expected to generate 1.87 times more return on investment than Travere Therapeutics. However, Ventyx Biosciences is 1.87 times more volatile than Travere Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Travere Therapeutics is currently generating about 0.1 per unit of risk. If you would invest 231.00 in Ventyx Biosciences on August 29, 2024 and sell it today you would earn a total of 23.00 from holding Ventyx Biosciences or generate 9.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ventyx Biosciences vs. Travere Therapeutics
Performance |
| Timeline |
| Ventyx Biosciences |
| Travere Therapeutics |
Ventyx Biosciences and Travere Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ventyx Biosciences and Travere Therapeutics
The main advantage of trading using opposite Ventyx Biosciences and Travere Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Travere Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Travere Therapeutics will offset losses from the drop in Travere Therapeutics' long position.| Ventyx Biosciences vs. Valneva SE ADR | Ventyx Biosciences vs. Bright Minds Biosciences | Ventyx Biosciences vs. HP Inc | Ventyx Biosciences vs. Intel |
| Travere Therapeutics vs. Cytokinetics | Travere Therapeutics vs. Ventyx Biosciences | Travere Therapeutics vs. Cogent Biosciences | Travere Therapeutics vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |